Dana S. Hutchinson

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.

Journal: Cell

Published: August 29, 2025

Contrasting roles for GLP-1R and GIPR in a model of diet-induced obesity.

Contrasting roles for GLP-1R and GIPR in a model of diet-induced obesity.

Journal: Journal of molecular endocrinology

Published: April 14, 2025

Advances in incretin therapies for targeting cardiovascular disease in diabetes.

Advances in incretin therapies for targeting cardiovascular disease in diabetes.

Journal: Journal of molecular and cellular cardiology

Published: November 01, 2024

Increased ATP production and P-glycoprotein activity underlie the marked changes in blood-brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis.

Increased ATP production and P-glycoprotein activity underlie the marked changes in blood-brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis.

Journal: British journal of pharmacology

Published: July 28, 2024

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.

Journal: Cell

Published: June 28, 2024

GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates.

GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates.

Journal: Expert opinion on investigational drugs

Published: February 19, 2024

The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis.

The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis.

Journal: Molecular metabolism

Published: January 12, 2024

Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Journal: Nature immunology

Published: December 12, 2023

Role of G protein-coupled receptor kinases (GRKs) in β2 -adrenoceptor-mediated glucose uptake.

Role of G protein-coupled receptor kinases (GRKs) in β2 -adrenoceptor-mediated glucose uptake.

Journal: Pharmacology research & perspectives

Published: September 12, 2023

Treatment of Diet-Induced Obese Rats with CB2 Agonist AM1241 or CB2 Antagonist AM630 Reduces Leptin and Alters Thermogenic mRNA in Adipose Tissue.

Treatment of Diet-Induced Obese Rats with CB2 Agonist AM1241 or CB2 Antagonist AM630 Reduces Leptin and Alters Thermogenic mRNA in Adipose Tissue.

Journal: International journal of molecular sciences

Published: March 06, 2023

Targeting G protein-coupled receptors for heart failure treatment.

Targeting G protein-coupled receptors for heart failure treatment.

Journal: British journal of pharmacology

Published: October 26, 2022

CB1 Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity.

CB1 Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity.

Journal: International journal of molecular sciences

Published: July 25, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026